These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39270843)
1. Long-term outcomes of mechanochemical ablation using the Clarivein device for the treatment of great saphenous vein incompetence. Oud S; Alozai T; Lam YL; Ünlü Ç; Mooij M; Schreve MA J Vasc Surg Venous Lymphat Disord; 2024 Sep; ():101967. PubMed ID: 39270843 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, dose-finding study of mechanochemical ablation using ClariVein and liquid polidocanol for great saphenous vein incompetence. Lam YL; Alozai T; Schreve MA; de Smet AAEA; Vahl AC; Nagtzaam I; Lawson JA; Nieman FHM; Wittens CHA J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):856-864.e2. PubMed ID: 34781008 [TBL] [Abstract][Full Text] [Related]
3. A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol. Alozai T; Lam YL; Schreve MA; de Smet AA; Vahl AC; Terlouw-Punt LC; Ünlü Ç; Wittens CH Phlebology; 2023 Sep; 38(8):532-539. PubMed ID: 37436708 [TBL] [Abstract][Full Text] [Related]
4. Early results of mechanochemical ablation for small saphenous vein incompetency using 2% polidocanol. Baccellieri D; Apruzzi L; Ardita V; Favia N; Saracino C; Carta N; Melissano G; Chiesa R J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):683-690. PubMed ID: 32916372 [TBL] [Abstract][Full Text] [Related]
5. Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2011; 11(1):1-93. PubMed ID: 23074413 [TBL] [Abstract][Full Text] [Related]
6. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. van Eekeren RR; Boersma D; Elias S; Holewijn S; Werson DA; de Vries JP; Reijnen MM J Endovasc Ther; 2011 Jun; 18(3):328-34. PubMed ID: 21679070 [TBL] [Abstract][Full Text] [Related]
7. Midterm Outcome of Mechanochemical Endovenous Ablation for the Treatment of Great Saphenous Vein Insufficiency. Witte ME; Holewijn S; van Eekeren RR; de Vries JP; Zeebregts CJ; Reijnen MM J Endovasc Ther; 2017 Feb; 24(1):149-155. PubMed ID: 27742900 [TBL] [Abstract][Full Text] [Related]
8. Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial). Holewijn S; van Eekeren RRJP; Vahl A; de Vries JPPM; Reijnen MMPJ; J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):364-374. PubMed ID: 31000063 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and short-term complication rate of mechanochemical ablation for epifascial tributaries of incompetent great saphenous veins. Kwon YW; Park SW; Hwang JH; Jang H; Min J; Hwang JJ; Lee SA; Kim JS; Chee HK J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):925-931. PubMed ID: 33186752 [TBL] [Abstract][Full Text] [Related]
10. Pain Outcomes Following Mechanochemical Ablation vs Cyanoacrylate Adhesive for the Treatment of Primary Truncal Saphenous Vein Incompetence: The MOCCA Randomized Clinical Trial. Belramman A; Bootun R; Tang TY; Lane TRA; Davies AH JAMA Surg; 2022 May; 157(5):395-404. PubMed ID: 35385061 [TBL] [Abstract][Full Text] [Related]
11. Severity of disease and treatment outcomes of anterior accessory great saphenous veins compared with the great saphenous vein. Deol ZK; Lakhanpal S; Pappas PJ J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):654-660. PubMed ID: 34438092 [TBL] [Abstract][Full Text] [Related]
12. Comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence: protocol for a multicentre, open-label, non-inferiority, observer-blinded, randomised controlled trial (REBORN trial). Oud S; Alozai T; Schreve MA; Mooij MC; van Vlijmen CJ; Ünlü Ç BMJ Open; 2024 Aug; 14(8):e087490. PubMed ID: 39117408 [TBL] [Abstract][Full Text] [Related]
13. Early results of an Asian prospective multicenter VenaSeal real-world postmarket evaluation to investigate the efficacy and safety of cyanoacrylate endovenous ablation for varicose veins. Tang TY; Yap CJQ; Chan SL; Soon SXY; Yap HY; Lee SQW; Choke ETC; Chong TT J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):335-345.e2. PubMed ID: 32387378 [TBL] [Abstract][Full Text] [Related]
14. Cyanoacrylate glue used to treat great saphenous reflux: Measures of outcome. Chan YC; Law Y; Cheung GC; Ting AC; Cheng SW Phlebology; 2017 Mar; 32(2):99-106. PubMed ID: 27052039 [TBL] [Abstract][Full Text] [Related]
15. Favorable long-term results of endovenous laser ablation of great and small saphenous vein incompetence with a 1470-nm laser and radial fiber. Pavei P; Spreafico G; Bernardi E; Giraldi E; Ferrini M J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):352-360. PubMed ID: 32599308 [TBL] [Abstract][Full Text] [Related]
16. Interventions for great saphenous vein incompetence. Whing J; Nandhra S; Nesbitt C; Stansby G Cochrane Database Syst Rev; 2021 Aug; 8(8):CD005624. PubMed ID: 34378180 [TBL] [Abstract][Full Text] [Related]
17. Effect of junctional reflux on the venous clinical severity score in patients with insufficiency of the great saphenous vein (JURY study). Vemuri C; Gibson KD; Pappas PJ; Sadek M; Ting W; Obi AT; Mouawad NJ; Etkin Y; Gasparis AP; McDonald T; Sahoo S; Sorkin JD; Lal BK J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101700. PubMed ID: 37956904 [TBL] [Abstract][Full Text] [Related]
18. Editor's Choice - Short Term Cost Effectiveness of Radiofrequency Ablation and High Ligation and Stripping for Great Saphenous Vein Incompetence. Nelzén O; Skoog J; Bernfort L; Zachrisson H Eur J Vasc Endovasc Surg; 2024 May; 67(5):811-817. PubMed ID: 38311050 [TBL] [Abstract][Full Text] [Related]
19. Correlation between great saphenous length of treatment zone and diameter with improvement in symptoms after ablation. Attaran RR; Bhalla A; Mena-Hurtado CI; Ochoa Chaar CI J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1443-1450. PubMed ID: 33706000 [TBL] [Abstract][Full Text] [Related]
20. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes. Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K; J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]